# BDPT (BioAdaptives Inc.) - SEC EDGAR Financial Statements

> BioAdaptives Inc. reported $26K in revenue and a net loss of $2.28M for the trailing twelve months ended September 30, 2026 (up 7.8% year over year), with a 77.0% gross margin and a -3610.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/BDPT
- Markdown: https://convexityos.com/fundamentals/BDPT.md
- SEC CIK: 0001575142
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:15 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001575142&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $26K | +7.8% YoY |
| Operating Income | TTM | -$936K | -3610.9% margin |
| Net Income | TTM | -$2.28M | -8805.9% net margin |
| Diluted EPS | TTM | -$0.15 | Split-adjusted |
| Free Cash Flow | TTM | -$534K | -2060.1% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2015 | FY 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $18K | $13K | $29K | $17K | $20K | $16K | $9.9K | -- | -- | -- |
| Cost of Revenue | $5.8K | $8.6K | $18K | $10K | $9.7K | $10K | $5.0K | -- | -- | -- |
| **Gross Profit** | $12K | $4.0K | $11K | $7.1K | $10K | $6.1K | $4.9K | -- | -- | -- |
| Total Operating Expenses | $1.05M | $606K | $240K | $429K | $646K | $260K | $239K | $658K | $227K | $2.44M |
| **Operating Income** | -$1.04M | -$602K | -$229K | -$422K | -$636K | -$254K | -$234K | -$658K | -$227K | -$2.44M |
| **EBITDA** | -$1.04M | -$600K | -- | -- | -- | -- | -- | -- | -$227K | -$2.44M |
| Interest Expense | $71K | $92K | $163K | $289K | $272K | $230K | $199K | -$248K | -- | -- |
| Income Before Tax | -$1.56M | -$899K | -- | -- | -- | -$847K | -$239K | -$1.41M | -- | -- |
| Income Tax Expense | $0 | $0 | -- | $0 | $0 | $0 | $0 | -- | -- | -- |
| **Net Income** | -$1.56M | -$899K | -$712K | -$896K | -$1.05M | -$847K | -$239K | -$1.41M | -$227K | -$2.58M |
| Basic EPS | -- | -$0.11 | -$0.12 | -- | -- | -$0.04 | -$0.01 | -$0.08 | -$0.02 | -$0.21 |
| **Diluted EPS** | -$0.15 | -$0.11 | -- | -- | -- | -$0.04 | -$0.01 | -$0.08 | -$0.02 | -$0.21 |
| Basic Shares Outstanding | -- | 8.2M | 6.0M | -- | -- | 20.4M | 18.7M | 17.0M | 12.7M | 12.5M |
| Diluted Shares Outstanding | 10.1M | 8.2M | -- | -- | -- | 20.4M | 18.7M | 17.0M | 12.7M | 12.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $5.0K | $5.0K | $5.5K | $10K | $4.6K | $3.2K | $0 | $0 |
| Cost of Revenue | $979 | $748 | $1.4K | $2.8K | $781 | $2.2K | $0 | $0 |
| **Gross Profit** | $4.0K | $4.2K | $4.1K | $7.6K | $3.9K | $1.1K | $0 | $0 |
| Total Operating Expenses | $297K | $201K | $202K | $256K | $270K | $280K | $249K | $337K |
| **Operating Income** | -$292K | -$197K | -$198K | -$248K | -$266K | -$279K | -$249K | -$337K |
| **EBITDA** | -$291K | -$196K | -$197K | -$247K | -$264K | -$353K | -$174K | -- |
| Interest Expense | $325 | -$87K | $88K | $37K | $14K | $9.6K | $9.6K | $9.7K |
| Income Before Tax | -$1.50M | $150K | -$111K | -$823K | -$380K | -$158K | -$197K | -- |
| **Net Income** | -$1.50M | $150K | -$111K | -$823K | -$380K | -$158K | -$197K | -$372K |
| Basic EPS | -$0.01 | $0.01 | -- | -- | -$0.04 | -$0.02 | -- | -- |
| **Diluted EPS** | -- | $0.00 | -$0.01 | -- | -$0.04 | -$0.02 | -$0.02 | -- |
| Basic Shares Outstanding | 166.8M | 14.2M | -- | -- | 10.2M | 9.5M | -- | -- |
| Diluted Shares Outstanding | -- | 281.2M | 12.0M | -- | 10.2M | 9.5M | 9.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2015 | FY 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $215K | $262K | $89K | $83K | $83K | $4.6K | $12K | $56K | $99 | $38K |
| Short-Term Investments | $0 | $0 | $0 | $42 | $190 | $444 | $772 | $4.0K | $4.9K | $30K |
| **Cash & Short-Term Investments** | $215K | $262K | $89K | $83K | $83K | $5.0K | $13K | $60K | $5.0K | $68K |
| Accounts Receivable, Net | -- | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Inventory | $45K | $19K | $15K | $8.9K | $4.8K | $14K | $11K | $50K | -- | -- |
| **Total Current Assets** | $212K | $262K | $89K | $34K | $89K | $19K | $24K | $110K | $6.7K | $70K |
| Property, Plant & Equipment, Net | $14K | $0 | -- | -- | -- | -- | -- | -- | $527 | $1.1K |
| Intangible Assets | $14K | $0 | $15K | $3.0K | -- | $0 | -- | -- | -- | -- |
| **Total Non-Current Assets** | $14K | $0 | $15K | $3.0K | $60K | $0 | $0 | $0 | $527 | $1.1K |
| **Total Assets** | $226K | $262K | $104K | $37K | $149K | $19K | $24K | $110K | $7.2K | $71K |
| Accounts Payable | -- | -- | -- | $0 | $1.8K | $5.4K | $1.3K | $40K | $34K | $2.5K |
| Other Current Liabilities | -- | $150K | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $2.36M | $1.73M | $1.75M | $1.49M | $1.24M | $1.40M | $864K | $716K | $211K | $71K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $88K | $0 | $0 |
| **Total Liabilities** | $2.36M | $1.73M | $1.75M | $1.49M | $1.24M | $1.40M | $864K | $804K | $211K | $71K |
| Common Stock | $1.2K | $821 | $597 | $25K | $5.1K | $2.2K | $1.9K | $1.8K | $1.3K | $1.3K |
| Retained Earnings | -$10.72M | -$9.16M | -$8.26M | -$7.55M | -$6.66M | -$5.61M | -$4.76M | -$4.52M | -$2.82M | -$2.59M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -- | -- | -- | -$57K | -$31K |
| **Total Stockholders' Equity** | -$2.13M | -$1.46M | -$1.65M | -$1.45M | -$1.09M | -$1.38M | -$840K | -$694K | -$203K | -$117 |
| Total Equity | -$2.13M | -$1.46M | -$1.65M | -$1.45M | -$1.09M | -$1.38M | -$840K | -$694K | -$203K | -$117 |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | $215K | -- | -- | -- | $262K |
| Short-Term Investments | -- | $0 | $0 | $0 | -- | -- | -- | $0 |
| **Cash & Short-Term Investments** | -- | -- | -- | $215K | -- | -- | -- | $262K |
| Accounts Receivable, Net | -- | -- | -- | -- | $59 | $59 | -- | $0 |
| Inventory | $34K | $36K | $43K | $45K | $44K | $40K | $41K | $19K |
| **Total Current Assets** | $48K | $68K | $123K | $212K | $109K | $256K | $110K | $262K |
| Property, Plant & Equipment, Net | $9.5K | $11K | $12K | $14K | $16K | $17K | -- | $0 |
| Intangible Assets | -- | -- | -- | $14K | -- | -- | -- | $0 |
| **Total Non-Current Assets** | $9.5K | $11K | $12K | $14K | $16K | $17K | $0 | $0 |
| **Total Assets** | $58K | $79K | $136K | $226K | $124K | $273K | $110K | $262K |
| Other Current Liabilities | -- | -- | -- | -- | $0 | -- | -- | $150K |
| **Total Current Liabilities** | $2.70M | $1.84M | $2.27M | $2.36M | $1.59M | $1.41M | $1.68M | $1.73M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $2.70M | $1.84M | $2.27M | $2.36M | $1.59M | $1.41M | $1.68M | $1.73M |
| Common Stock | $22K | $3.7K | $1.2K | $1.2K | $1.1K | $994 | $904 | $821 |
| Retained Earnings | -$12.18M | -$10.68M | -$10.83M | -$10.72M | -$9.90M | -$9.52M | -$9.36M | -$9.16M |
| **Total Stockholders' Equity** | -$2.65M | -$1.77M | -$2.14M | -$2.13M | -$1.47M | -$1.23M | -$1.57M | -$1.46M |
| Total Equity | -$2.65M | -$1.77M | -$2.14M | -$2.13M | -$1.47M | -$1.23M | -$1.57M | -$1.46M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2015 | FY 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.56M | -$899K | -$712K | -$896K | -$1.05M | -$847K | -$239K | -$1.41M | -$227K | -$2.58M |
| Depreciation & Amortization | $4.0K | $1.9K | -- | -- | -- | -- | -- | -- | $528 | $527 |
| Stock-Based Compensation | $29K | -- | -- | $0 | $164K | $47K | $0 | $273K | $50K | $1.64M |
| Change in Receivables | -$59 | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Change in Inventory | -$26K | -$25K | -$6.4K | -$4.1K | $9.1K | $2.7K | -$39K | $50K | -- | -- |
| Change in Payables | -- | -- | -- | -- | -- | -- | -- | -- | $160K | $2.5K |
| **Operating Cash Flow** | -$516K | -$250K | -$224K | -$227K | -$159K | -$107K | -$168K | -$420K | -$72 | -$59K |
| Capital Expenditure | -$18K | $0 | -- | -- | -- | -- | -- | -- | -- | $1.6K |
| **Free Cash Flow** | -$534K | -$250K | -- | -- | -- | -- | -- | -- | -- | -$57K |
| **Investing Cash Flow** | -$18K | $0 | -- | -- | -- | -- | -- | $32K | -- | -$1.6K |
| Common Stock Issued | -- | $0 | $178K | $0 | $565K | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $555K | $326K | $259K | $170K | $237K | $99K | $124K | $426K | -$38K | $79K |
| **Net Change in Cash** | $21K | $77K | $35K | -$58K | $78K | -$7.7K | -- | -- | -$38K | $19K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.50M | $150K | -$111K | -$823K | -$380K | -$158K | -$197K | -$1.43M |
| Depreciation & Amortization | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | -$74K | $75K | -- |
| Stock-Based Compensation | -- | -- | -- | -- | -- | $29K | -- | -- |
| Change in Inventory | $1.8K | $6.9K | $1.7K | -$478 | -$4.7K | $1.0K | -$21K | -$19K |
| **Operating Cash Flow** | -$114K | -$44K | -$85K | -$156K | -$151K | -$111K | -$98K | -$101K |
| **Net Change in Cash** | -$24K | -$44K | -$85K | $99K | -$151K | $171K | -$98K | $94K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2015 | FY 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 68.4% | 31.8% | 37.9% | 41.5% | 51.1% | 37.3% | 49.2% | -- | -- | -- |
| **Operating Margin** | -5701.8% | -4752.5% | -801.4% | -2456.3% | -3216.4% | -1557.7% | -2359.6% | -- | -- | -- |
| **Net Profit Margin** | -8523.4% | -7097.3% | -2494.2% | -5214.1% | -5309.2% | -5189.2% | -2405.1% | -- | -- | -- |
| Return on Assets (ROA) | -689.6% | -343.3% | -685.1% | -2400.1% | -706.6% | -4495.6% | -986.8% | -1278.1% | -3163.2% | -3639.6% |
| Current Ratio | 0.09x | 0.15x | 0.05x | 0.02x | 0.07x | 0.01x | 0.03x | 0.15x | 0.03x | 0.98x |
| Quick Ratio | 0.07x | 0.14x | 0.04x | 0.02x | 0.07x | 0.00x | 0.02x | 0.08x | 0.02x | 0.96x |
| **Revenue Growth (YoY)** | +44.3% | -55.6% | +66.3% | -13.1% | +21.1% | +64.4% | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +210.1% | -62.8% | +51.8% | -29.5% | +65.8% | +24.8% | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -- | +189.5% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 77.0% | 77.4% | 69.8% | 68.4% | 62.6% | 33.0% | 63.6% | 31.8% |
| **Operating Margin** | -3610.9% | -3557.0% | -4166.3% | -5701.8% | -14410.8% | -30681.8% | -118726.8% | -4752.5% |
| **Net Profit Margin** | -8805.9% | -4553.2% | -6186.3% | -8523.4% | -14091.7% | -23749.2% | -116976.3% | -7097.3% |
| Return on Assets (ROA) | -3969.4% | -1477.6% | -1082.6% | -689.6% | -889.6% | -280.5% | -714.9% | -343.3% |
| Current Ratio | 0.02x | 0.04x | 0.05x | 0.09x | 0.07x | 0.18x | 0.07x | 0.15x |
| Quick Ratio | 0.01x | 0.02x | 0.04x | 0.07x | 0.04x | 0.15x | 0.04x | 0.14x |
| **Revenue Growth (YoY)** | +7.8% | +55.0% | -- | -- | -- | +376.9% | -100.0% | -100.0% |
| Gross Profit Growth (YoY) | +4.2% | +298.9% | -- | -- | -- | +147.8% | -100.0% | -100.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
